Levetiracetam
Elepsia XR is an extended-release tablet containing levetiracetam, an anticonvulsant medication used to treat seizures in epilepsy. Available in 1000 mg and 1500 mg strengths, it's taken orally and was manufactured by TriPoint Therapeutics, LLC. Note: This product is discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Elepsia XR is an extended-release tablet containing levetiracetam, an anticonvulsant medication used to treat seizures in epilepsy. Available in 1000 mg and 1500 mg strengths, it's taken orally and was manufactured by TriPoint Therapeutics, LLC. Note: This product is discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Levetiracetam",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Levetiracetam — ANDA 078858 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078858"
}
]
|
| identifier | ANDA078858 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-safety",
"fda",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Levetiracetam |
